Public Policy Committee

BioNJ’s Public Policy Committee serves as an important sounding board for BioNJ’s public policy efforts. The committee is comprised of executive and policy leadership in New Jersey’s life sciences innovation sector, from CEOs to government relations personnel and others. The committee meets regularly to provide BioNJ with feedback on policy machinations in Trenton and beyond; while participating in monthly update calls with BioNJ staff. Committee members frequently hear from guest speakers, including legislators, administrative and regulatory leaders, and others in the life sciences community at committee meetings, events and receptions.

Committee Members

Adastra Pharmaceuticals, Inc. – Scott Megaffin, CEO
Allergan – Loredana Cromarty, MGA, Associate Vice President, Government Affairs
Bristol-Myers Squibb Company – Ethan Hasbrouck, MPA, State Government Affairs
Celgene Corporation – Dmitri Siegel, MBA, Director, State Government Relations, NE Region
Chair, Public Policy Committee – Ambaw Bellete
Eli Lilly & Company – Timothy Lyden, Director, State Government and Business Affairs
Ferring Pharmaceuticals, Inc. – Ed Trott, Chief Patient Officer
Former Chairman, BioNJ Board of Trustees – James Sapirstein, MBA, RPh
Ipsen US – Bob Feeney, MBA, Vice President, NA Government Affairs and Public Policy
J&J – Chris Guiton, JD, Senior Director, US State Government Affairs
Jade River Pharma, LLC – John Maki, President & CEO
Merck & Co., Inc. – Domenick Argento, Associate Director, Account Management, Government Affairs & Policy
Novartis Pharmaceuticals – Candie Phipps, Director, State Government and Business Affairs
Novo Nordisk – Brian Kelly, JD, Director, State Government Affairs
OncoSec Medical Inc. – Daniel O’Connor, JD, CEO
Pfizer, Inc. – Wendy Lazarus, Director, U.S. Government Relations
Rigby Consulting, LLC – Kevin Rigby, JD, Principal
Sanofi – George Coutros, Director, State Government Affairs
Soligenix, Inc. – Dennis Ondrejik, Program Manager
Translatum Medicus, Inc. – Paul Howes MBA, Executive Vice President
Tyme Technologies, Inc. – Michele Korfin, MBA, CCO